Sex differences in the discriminative stimulus effects of m- chlorophenylpiperazine and ethanol withdrawal

Psychopharmacology

Volumn 149, Issue 2, 2000, Pages 170-175

  Jung, Marianna E ^a   Wallis, Cleatus J ^a   Gatch, Michael B ^a   Lal, Harbans ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

17 estradiol; Anxiety; Drug discrimination; Ethanol withdrawal; m Chlorophenylpiperazine; Rat; Sex difference

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; ALCOHOL; ESTRADIOL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DISCRIMINATION; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; SEX; SEX DIFFERENCE;

EID: 0034092447     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002139900353     Document Type: Article

References (46)

1. Astiningsih K, Rogers L (1996) Sensitivity to testosterone varies with strain, sex, and site of action in chickens. Physiol Behav 59:1085-1091
2. Bonventre J, Valanju S, Bastos ML (1982) Evaluation of ethanol analysis on brain and liver by head-space gas chromatography. Forensic Sci Int 19:75-83
3. Callahan PM, Cunningham KA (1994) Involvement of 5-HT2 C receptors imediating the discriminative stimulus properties of m-chlorophenyl-piperazine (mCPP). Eur J Pharmacol 257:27-38
4. Chen H, Casanova M, Kleinman J, Zito M, Goldman D, Linnoila M (1991) 3H-paroxetine binding in brains of alcoholics. Psychiatry Res 38:293-299
5. Devaud L, Purdy R, Morrow A (1995) The neurosteroid, 3 alpha-hydroxy-5 alpha-pregnan-20-one, protects against bicuculline-induced seizures during ethanol withdrawal in rats. Alcohol Clin Exp Res 19:350-355
6. Devaud L, Fritschy J, Morrow A (1998) Influence of gender on chronic ethanol-induced alterations in GABAA receptors in rats. Brain Res 796:222-230
7. Dodd H, Shorey-Kutschke R (1987) Ethanol lowers heart carnitine in the methionine and choline deficient rat. Alcohol 4:395-399
8. Emmett-Oglesby M, Spencer DJ, Arnoult D (1982) A TRS-80-based system for the control of behavioral experiments. Pharmacol Biochem Behav 17:583-587
9. Gatch MB, Lal H (1998) Pharmacological treatment of alcohol-ism. Prog Neuropsychopharmacol Biol Psychiatry 22:917-944
10. Gatch MB, Wallis CJ, Lal H (2000) Effects of ritanserin on ethanol withdrawal induced anxiety in rats. Alcohol (in press)
11. George D, Benkelfat C, Rawlings R, Eckardt M, Phillips M, Nutt D, Wynne D, Murphy D, Linnoila M (1997) Behavioral and neuroendocrine responses to m-chlorophenylpiperazine in subtypes of alcoholics and in healthy comparison subjects. Am J Psychiatry 154:81-87
12. Germine M, Goddard A, Woods S, Charney D, Heninger G (1992) Anger and anxiety responses to m-chlorophenylpiperazine in generalized anxiety disorder. Biol Psychiatry 32:457-461
13. Goldberg SR, Schuster CR (1967) Conditioned suppression by a stimulus associated with nalorphine in morphine-dependent monkeys J Exp Anal Behav 10:235-242
14. Goldberg SR, Schuster CR (1970) Conditioned nalorphine-induced abstinence changes: persistence in post morphine-dependent monkeys J Exp Anal Behav 14:33-46
15. Heinsbroek R, Feenstra M, Boon P, Van Haaren F, Van de Poll N (1988) Sex differences in passive avoidance depend on the integrity of the central serotonergic system. Pharmacol Biochem Behav 31:499-503
16. Heinsbroek R, van Haaren F, Feenstra M, van Galen H, Boer G, van de Poll N (1990) Sex differences in the effects of inescapable footshock on central catecholaminergic and serotonergic activity. Pharmacol Biochem Behav 37:539-550
17. Idemudia SO, Bhadra S, Lal H (1989) The pentylenetetrazol-like interoceptive stimulus produced by ethanol withdrawal is potentiated by bicuculline and picrotoxinin. Neuropsychopharmacology 2:115-122
18. Institute of Laboratory Animal Resources (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington, DC
19. Jaffe J, Kranzler H, Ciraulo D (1992) Drugs used in the treatment of alcoholism. In: Mendelson J, Mello N (eds) Medical treatment and diagnosis of alcoholism. McGraw-Hill, New York, pp 421-461
20. Johnston A, File S (1991) Sex differences in animal tests of anxiety. Physiol Behav 49:245-250
21. Jung M, Wallis C, Gatch M, Lal H (1999) Sex differences in the pentylenetetrazol-like stimulus induced by ethanol withdrawal. J Pharmacol Exp Ther 291:576-582
22. Katz M, Wetzler S, Cloitre M, Swann A, Secunda S, Mendels J, Robins E (1993) Expressive characteristics of anxiety in depressed men and women. J Affect Disord 28:267-277
23. Klein E, Zohar J, Geraci M, Murphy D, Uhde T (1991) Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects. Biol Psychiatry 30:973-984
24. Klodzinska A, Jaros T, Chojnacka-Wojcik E, Maj J (1989) Exploratory hypoactivity induced by m-trifluoromethylphenylpiperazine (TFMPP) and m-chlorophenylpiperazine (m-CPP). J Neural Transm Basic Neurosci Neurol Sect Psychiatry Sect 1: 207-218
25. Kokka N, Sapp D, Witte U, Olsen R (1992) Sex differences in sensitivity to pentylenetetrazol but not in GABAA receptor binding. Pharmacol Biochem Behav 43:441-447
26. Krystal J, Webb E, Cooney N, Kranzler H, Southwick S, Heninger G, Charney D (1996) Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects. Am J Psychiatry 153:83-92
27. Lal H, Harris CM, Benjamin D, Springfield AC, Bhadra S, Emmett-Oglesby MW (1988) Characterization of a pentylenetetrazol-like interoceptive stimulus produced by ethanol withdrawal. J Pharmacol Exp Ther 247:508-518
28. Lal H, Prather PL, Rezazadeh SM (1991) Anxiogenic behavior in rats during acute and protracted ethanol withdrawal: reversal by buspirone. Alcohol 8:467-471
29. Lal H, Prather PL, Rezazadeh SM (1993) Potential role of 5HT1 C and/or 5HT2 receptors in the mianserin-induced prevention of anxiogenic behaviors occurring during ethanol withdrawal. Alcohol Clin Exp Res 17:411-417
30. Lawlor B, Sunderland T, Hill J, Mellow A, Molchan S, Mueller E, Jacobsen F, Murphy D (1989) Evidence for a decline with age in behavioral responsivity to the serotonin agonist, m-chlorophenylpiperazine, in healthy human subjects. Psychiatry Res 29:1-10
31. Litten R, Allen J (1991) Pharmacotherapies for alcoholism: promising agents and clinical issues. Alcohol Clin Exp Res 15: 620-633
32. Mora PO, Netto CF, Graeff FG (1997) Role of 5-HT2 A and 5-HT2 C receptor subtypes in the two types of fear generated by the elevated T-maze. Pharmacol Biochem Behav 58:1051-1057
33. Naranjo C, Bremner K (1994) Serotonin-altering medications and desire, consumption and effects of alcohol-treatment implications. EXS 71:209-219
34. Pigott T, Zohar J, Hill J, Bernstein S, Grover G, Zohar-Kadouch R, Murphy D (1991) Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder. Biol Psychiatry 29:418-426
35. Prather PL, Lal H (1992) Protracted withdrawal: sensitization of the anxiogenic response to cocaine in rats concurrently treated with ethanol. Neuropsychopharmacology 6:23-29
36. Prather PL, Rezazadeh SM, Lal H (1991) Mianserin in the treatment of ethanol withdrawal in the rat: prevention of behaviors indicative of anxiety. Psychopharmacol Bull 27:285-289
37. Rezazadeh SM, Prather PL, Lal H (1993) Sensitization to 5-HT1 C receptor agonist in rats observed following withdrawal from chronic ethanol. Alcohol 10:281-283
38. Setem J, Pinheiro AP, Motta VA, Morato S, Cruz AP (1999) Ethopharmacological analysis of 5-HT ligands on the rat elevated plus-maze. Pharmacol Biochem Behav 62:515-521
39. Shader R, Greenblatt D (1995) The pharmacotherapy of acute anxiety. In: Bloom F, Kupfer D (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 1341-1348
40. Sutker P, Tabakoff B, Goist KJ, Randall C (1983) Acute alcohol intoxication, mood states and alcohol metabolism in women and men. Pharmacol Biochem Behav 18[suppl 1]:349-354
41. Ulrichsen J, Partilla J, Dax E (1992) Long-term administration of m-chlorophenylpiperazine (mCPP) to rats induces changes in serotonin receptor binding, dopamine levels and locomotor activity without altering prolactin and corticosterone secretion. Psychopharmacology 107:229-235
42. Wallis CJ, Lal H (1998) A discriminative stimulus produced by 1-(3-chlorophenyl)-piperazine (mCPP) as a putative animal model of anxiety. Prog Neuropsychopharmacol Biol Psychiatry 22:547-565
43. Wilson M, Biscardi R (1994) Sex differences in GABA/benzodiazepine receptor changes and corticosterone release after acute stress in rats. Exp Brain Res 101:297-306
44. Winter JC, Rabin RA (1993) Discriminative stimulus properties of m-chlorophenylpiperazine. Pharmacol Biochem Behav 45: 221-223
45. Woods J, Katz J, Winger G (1992) Benzodiazepines: use, abuse, and consequences. Pharmacol Rev 44:151-347
46. Zimmerberg B, Farley MJ (1993) Sex differences in anxiety behavior in rats: role of gonadal hormones. Physiol Behav 54: 1119-1124